This test is intended for use as an aid in the management of patients with chronic HBV infection undergoing antiviral therapy. The test can be used to measure HBV DNA levels at baseline and during treatment to aid in assessing response to treatment. The results from this test must be interpreted within the context of all relevant clinical and laboratory finding.
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HCV infected patients.
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HCV infected patients. The test can be used to monitor the HCV RNA level during the course of antiretroviral treatment.
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to assess the baseline HIV-1 RNA level.
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to monitor the HIV-1 RNA level during the course of antiretroviral treatment.
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to monitor the HIV-1 RNA level during the course of antiretroviral treatment.
Epstein-Barr virus (EBV) is the cause of a variety of disorders, including infectious mononucleosis (IM). Laboratory testing can help determine whether someone is susceptible to EBV infection or has a recent or past infection.
Epstein-Barr virus (EBV) is the cause of a variety of disorders, including infectious mononucleosis (IM). Laboratory testing can help determine whether someone is susceptible to EBV infection or has a recent or past infection.
CMV infection is of clinical significance primarily in pregnant women, new-born infants with possible congenital infection, immunosuppressed transplant patients and immunocompromised individuals.
CMV infection is of clinical significance primarily in pregnant women, new-born infants with possible congenital infection, immunosuppressed transplant patients and immunocompromised individuals.
HSV (Herpes Simplex Virus) I & II Qualitative Detection
Molecular RT PCR
Random
EDTA whole blood (3ml)
1 day
DNA testing is analytically more sensitive than culture, especially in patients with encephalitis or meningitis. DNA testing may be useful in diagnosis of infection in neonates. Neonates who have been exposed to HSV can develop disseminated infection and encephalitis. Encephalitis is usually due to HSV I whereas meningitis is usually due to HSV II. DNA testing provides reliable means to define the type.
This test is intended to diagnose Dengue fever infection during the initial stage of infection, days 1-5 after onset of symptoms, which is able to detect dengue virus subtypes 1-4.
